M&A Deal Summary |
|
|---|---|
| Date | 2016-04-08 |
| Target | Instituto Biomar - Production Assets |
| Sector | Life Science |
| Buyer(s) | 4D pharma |
| Sellers(s) | Biomar Microbial Technologies |
| Deal Type | Divestiture |
SEARCH BY
4D pharma is a developer of live biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacteria, that is applicable to the prevention, treatment or cure of a disease. 4D has developed a proprietary platform, MicroRx, that rationally identifies novel bacteria that have a precise and evolved therapeutic effect. All of 4D's live biotherapeutic products are orally delivered single strains of bacteria that are naturally found in the healthy human gut. 4D currently has a pipeline of 15 therapeutic programmes covering autoimmune diseases, CNS disorders and cancer; with two programmes in patient trials, and the expectation to initiate another three programmes over the coming twelve months. 4D pharma was founded in 2014 and is based in Leeds, the United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: Spain M&A | 1 of 1 |
| Year: 2016 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-02-10 |
Tucana Health
Dublin, Ireland Tucana Health Ltd. is a start-up company from University College Cork. Tucana was founded by Prof. Fergus Shanahan and Prof. Paul O’Toole to investigate the use of microbiome signatures to aid the diagnosis and treatment of diseases. |
Buy | - |
Biomar Microbial Technologies is a Spanish based contract research organisation specialising in microbial fermentation. Biomar had initially focused on research into marine microorganisms and their use in pharmaceutical, bio-energy and food production. In 2001 it began to expand its technologies into microbial fermentation, providing contract services in this field and expanding its production capabilities up to 3,000 litres in 2010.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: Spain M&A | 1 of 1 |
| Year: 2016 M&A | 1 of 1 |
